α-PCYP
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H25NO |
Molar mass | 271.404 g·mol−1 |
3D model (JSmol) | |
| |
|
α-PCyP (α-PyrrolidinoCyclohexanoPhenone) is a stimulant drug of the cathinone class that has been sold online as a designer drug. In a series of alpha-substituted pyrrolidinyl cathinone derivatives developed in 2015, the alpha-cyclopentyl derivative was found to have around the same potency in vitro as an inhibitor of the dopamine transporter as the alpha-propyl derivative α-PVP, while the alpha-cyclohexyl derivative α-PCyP was around twice as strong.[2][3][4]
See also
[edit]- PCPy
- Picilorex
- α-PHP
- α-PHiP
- Alpha-D2PV
- βk-Ephenidine
- Diphenidine
- Indapyrophenidone
- UWA-101
- Zylofuramine
References
[edit]- ^ "§ 54.1-3446. Schedule I." Virginia Law. Retrieved 14 September 2023.
- ^ Kolanos R, Sakloth F, Jain AD, Partilla JS, Baumann MH, Glennon RA (October 2015). "Structural Modification of the Designer Stimulant α-Pyrrolidinovalerophenone (α-PVP) Influences Potency at Dopamine Transporters". ACS Chemical Neuroscience. 6 (10): 1726–31. doi:10.1021/acschemneuro.5b00160. PMC 5349767. PMID 26217965.
- ^ Glennon RA, Dukat M (2016). "Structure-Activity Relationships of Synthetic Cathinones". Current Topics in Behavioral Neurosciences. 32: 19–47. doi:10.1007/7854_2016_41. ISBN 978-3-319-52442-9. PMC 5818155. PMID 27830576.
- ^ Baumann MH, Walters HM, Niello M, Sitte HH (2018). "Neuropharmacology of Synthetic Cathinones". New Psychoactive Substances. Handbook of Experimental Pharmacology. Vol. 252. pp. 113–142. doi:10.1007/164_2018_178. ISBN 978-3-030-10560-0. PMC 7257813. PMID 30406443.